Prescription Pharmaceutical News from “The Pink Sheet” DAILY

For Novartis, 2012 Is Set To Be A Bumpy Ride / With the loss of exclusivity for its blockbuster heart drug, Diovan, coming in September, management focused on the company’s long-term prospects during a fourth quarter financial update. / “The Pink Sheet”

OTCs and Nutritionals from “The Tan Sheet”

Olympics Are A “Wild Card” For Supplement Industry Publicity / The Olympics inspire fitness enthusiasts to improve performance, which could translate to higher sales of legitimate nutritionals, herbals and other dietary supplements, but if athletes blame supplements for drug testing violations, the industry incurs bad publicity and consumer confidence slips. / “The Tan Sheet”

Medical Device News from “The Gray Sheet”

Medicare Panel Looks To Upcoming Study To Fill Evidence Gaps For Carotid Artery Disease / There is a lot more to learn about which treatment to choose for carotid atherosclerosis patients, Medicare advisors said this week. A new trial in the works that would compare both surgery and stenting to standalone medical therapy presents a good opportunity to fill the gaps. / “The Gray Sheet”

Top Medical News from Elsevier Global Medical News

Gastric Cancer Subtype May Affect Bevacizumab Benefit / New analysis shows one-third reduction in risk of death for patients with diffuse or distal gastric cancer. / Elsevier Global Medical News